Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_assertion type Assertion NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_head.
- NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_assertion description "[The pharmacodynamic effects of seliciclib, a cyclin-dependent kinase (CDK) inhibitor, were studied in patients with nasopharyngeal carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_provenance.
- NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_assertion evidence source_evidence_literature NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_provenance.
- NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_assertion SIO_000772 19228744 NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_provenance.
- NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_assertion wasDerivedFrom befree-2016 NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_provenance.
- NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_assertion wasGeneratedBy ECO_0000203 NP721410.RA_vjyxQoA05GstV7TtMi8EPPI0l2zwwDQU0pNn8z8nFc130_provenance.